KONOWIECKI JOSEPH S sold $35K of ALHC

KONOWIECKI JOSEPH S (EVP, Corporate Affairs) sold 4,930 shares of Alignment Healthcare, Inc. (ALHC) at $7.20 on 2026-11-10.

Original reporting
SEC EDGAR · KONOWIECKI JOSEPH S
Published Nov 12, 2026, 10:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 11:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALHC
Neutral
high confidence
Mentioned
$ALHC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCNeutralLow
01

Why it matters

The disclosed sale is small and unlikely to affect market perception of Alignment Healthcare.

02

Market read

Minor insider sell with limited trading relevance.

03

What to watch

Insider retains over a million shares, indicating continued confidence.

Relevance 3/10Novelty 3/10Timing: after-hours filing

Background

SEC Form 4 filings provide primary disclosure of insider transactions.

Company-level read

Ticker impact

$ALHCNeutralHigh confidence
Context

Form 4 disclosed EVP Joseph Konowiecki sold 4,930 shares of Alignment Healthcare at $7.20 each, total $35.5K.

Expected impact

possible modest pressure as market prices in the insider sell

Evidence & confidence

The transaction size is minor relative to total holdings and market cap; typical insider sales have limited impact.

Market effects

None significant for healthcare sector.

No regional effect.

Minimal.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Alignment Healthcare, Inc.

    NASDAQ-listed biotech focused on healthcare solutions.

  • Joseph S. Konowiecki

    Executive Vice President, Corporate Affairs at Alignment Healthcare.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.